Ozempic (Glucagon-like peptide 1 receptor agonist) in social media posts: Unveiling user perspectives through Reddit topic modeling
Semaglutide, a Glucagon-like peptide 1 (GLP-1) receptor agonist marketed under the brand name Ozempic, is originally prescribed for diabetes treatment and obesity management. However, healthy individuals without a medical cause use Ozempic without medical supervision to improve their physical appear...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Emerging Trends in Drugs, Addictions, and Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667118224000163 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|